Matthew Smith - Amdocs Corporate Secretary

DOX Stock  USD 85.67  0.47  0.55%   

Executive

Mr. Matthew Smith serves as Secretary, Head Investor Relations of Amdocs Limited. He was Secretary of Amdocs Limited since January 2015. Mr. Smith joined Amdocs in October 2012 as Director of Investor Relations and was Head of Investor Relations since January 2014. Prior to joining Amdocs, from April 2006 to August 2012, Mr. Smith was a research director at A.I. Capital Management, a hedge fund, where he covered many sectors, including the technology subsectors of IT hardware, semiconductors, software and IT services. From April 2001 to April 2006, Mr. Smith was an equity analyst at CIBC World Markets . since 2015.
Age 52
Tenure 9 years
Address 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141
Phone314 212 7000
Webhttps://www.amdocs.com

Matthew Smith Latest Insider Activity

Tracking and analyzing the buying and selling activities of Matthew Smith against Amdocs stock is an integral part of due diligence when investing in Amdocs. Matthew Smith insider activity provides valuable insight into whether Amdocs is net buyers or sellers over its current business cycle. Note, Amdocs insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amdocs'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Amdocs Management Efficiency

The company has Return on Asset of 0.0738 % which means that on every $100 spent on assets, it made $0.0738 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1405 %, implying that it generated $0.1405 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2024. Return On Capital Employed is likely to drop to 0.14 in 2024. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.
Amdocs has 807.31 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Amdocs has a current ratio of 1.57, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Amdocs to invest in growth at high rates of return.

Similar Executives

Showing other executives

EXECUTIVE Age

Todd PollakMarqeta
49
Matthew OConnorVeritone
N/A
Brian CFAVeritone
N/A
Melanie StrateDigitalOcean Holdings
N/A
Mark WilsonBlackBerry
N/A
Robert LantzNextnav Acquisition Corp
61
Bratin SahaDigitalOcean Holdings
N/A
Alan JDDigitalOcean Holdings
55
Keenan JDSentinelOne
61
Scott BogdanVeritone
N/A
Heather GanttEvansMarqeta
N/A
Alan CarlisleMarqeta
50
Fabio FerreiraGlobal Blue Group
51
Remo CanessaZscaler
67
Michael ZemetraVeritone
53
Cherie BarrettDigitalOcean Holdings
51
Seth GreenbergVeritone
60
David KnutsonNextnav Acquisition Corp
54
Rob IRCDigitalOcean Holdings
N/A
Joyce KimZscaler
55
Philip CFABlackBerry
N/A
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. Amdocs (DOX) is traded on NASDAQ Exchange in USA. It is located in 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141 and employs 11 people. Amdocs is listed under IT Consulting & Other Services category by Fama And French industry classification.

Management Performance

Amdocs Leadership Team

Elected by the shareholders, the Amdocs' board of directors comprises two types of representatives: Amdocs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amdocs. The board's role is to monitor Amdocs' management team and ensure that shareholders' interests are well served. Amdocs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amdocs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Joshua Sheffer, CEO President
Darcy Antonellis, Head Media
Oren Marmur, Head Network
Gary Miles, Chief Officer
Matthew Smith, Corporate Secretary
Avishai Sharlin, GM President
Mustafa Oyumi, Head Strategy
Idit Aronsohn, Inclusion Responsibility
Tamar RapaportDagim, Senior Vice President and CFO of Amdocs Management Limited
Anthony Goonetilleke, Group Strategy
Rajat Raheja, Division President Amdocs Development Center India Pvt. Ltd

Amdocs Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amdocs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.